<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2014-09-14 03:12:34Clinical research Pharmaceutical industry Design of experiments Medical ethics Institutional review board Clinical trial Pharmacovigilance Office for Human Research Protections Adverse event Human subject research Serious adverse event Adverse effect |
Add to Reading List |
Microsoft Word - Unanticipated_Problems | Microsoft Word - SOP editedonlineversibaru.docDocID: 1rqX4 - View Document |
| Microsoft Word - Abbreviations List Approved Oct 2014DocID: 1qCp5 - View Document |
| Statement German Network for Evidence-based Medicine Berlin, 05 JulyThe German Network for Evidence-based Medicine endorses theDocID: 1qiz3 - View Document |
| Microsoft Word - Unanticipated_ProblemsDocID: 1pvDq - View Document |
| PHARMACOVIGILANCE GUIDE FOR ADVERSE DRUG REACTION MONITORING AND CAUSALITY ASSESSMENT, 2015 Post marketing Control Division,DocID: 1p9e5 - View Document |